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Abstract: A comparison between the two most common reduction 
approaches for obtaining chiral amines, asymmetric hydrogenation 
(AH) versus asymmetric transfer hydrogenation (ATH), was 
accomplished by using iridium complexes based on atropoisomeric 
diphosphines and cyclic diamines as ligands respectively. Seven 
substrates, different in electronic and steric properties, were 
screened applying both reduction methods. For AH the best results 
in terms of enantioselectivity (e.e. up to 64%) were obtained by 
using [Ir(COD)(TetraMe-BITIOP)]Cl in the presence of DCDMH as 
additive. ATH was carried out with [IrCp*(CAMPY)Cl]Cl as catalyst, 
allowing the obtainment of the products with appreciable e.e. (up to 
76%). 
Introduction 
Enantiopure amines are key functionalities in many 
biologically active molecules. For this reason, extensive efforts 
are made with the aim to develop an efficient and practical 
method of their preparation.[1] Although a plethora of approaches 
is reported for their synthesis, the asymmetric metal-catalysed 
reduction of imine precursors is considered as an industrially 
valuable process. Asymmetric Hydrogenation (AH) exploits the 
use of organometallic complexes bearing chiral atropoisomeric 
diphosphines as catalysts and it is still a very efficient approach 
to obtain optically enriched amines.[2] The introduction of 
transition metal complexes based on chiral 1,2-diamines, and in 
particular Ts-DPEN and its derivatives,[3] it was possible to skip 
gaseous hydrogen and to use of a different hydrogen donor 
such as HCOOH, HCOONa, azeotropic mixture 
5:2=TEA:HCOOH or iPrOH. These catalytic systems proved 
extremely efficient in the asymmetric transfer hydrogenation 
(ATH) of ketones and alkenes, but only in few cases it was 
applied to the challenging reduction of imines affording high 
enantioselectivity.[4]  
Figure 1. Example of alkaloids with pharmacological properties. 
Despite the achievements made in this field,[5] the 
asymmetric reduction of cyclic imines, such as 
dihydroquinolines, isoquinolines and quinolines, important 
pharmaceutical intermediates for the production of complex 
alkaloids and unnatural β-amino acids, is still an unmet goal, 
thus proving the need for further investigations. [6] (Figure 1) 
In the context of this study, in which the two reduction 
methods resulted comparable or/and complementary, we 
decided to take into consideration two different isoquinolines, A 
and B, the salsolidine precursor C, as standard substrate for 
3,4-dihydroquinolines, its derivatives D and E, the quinoline F 
and the sulfonyl imine G. (Figure 2) 
Figure 2. Different evaluated cyclic imines 
AH reactions were evaluated using Ir(I) cyclooctadiene complex 
bearing a chiral basic atropoisomeric diphoshine in the presence 
of H2, while for ATH reactions, [Ir(III)Cp*L2] complexes were 
employed as catalysts, in which L2 is a rigid chiral diamine. 
Moreover, in both AH and ATH, the effect on reactivity and 
selectivity of different substrates was evaluated and remarkably 
all the ATH reactions were conducted in different aqueous 
buffers, thus avoiding the use of organic solvents. 
Results and Discussion 
Recently, the efficient enantioselective hydrogenation of different 
3,4-disubstituted isoquinolines employing an iridium catalyst in 
association with atropoisomeric ligands and in the presence of a 
halogen-activator is reported.[7] These substituted hydantoins 
are known to have a critical role in the catalytic cycle of the 
catalyst.[8] the above mentioned system bearing as ligand the 
atropoisomeric diphosphine (R)-Synphos is able to reduce these 
substrates in excellent yield and with modest to excellent 
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enantioselectivity based on the electronic and steric properties 
of the molecules. Taking into account these results, we decided 
to investigate the potential ability of the more basic members[9] 
of the class of diphosphines in the reduction of the iminic 
substrates A, B and C, this last one as standard substrate for 
3,4-dihydroquinolines. These diphosphines are derived from the 
condensation of the thiophene ring, like TetraMe-BITIANP, 
BITIANP and TetraMe-BITIOP.[10] The two 3,4-disubstituted 
isoquinolines were chosen considering the possible application 
of the corresponding tetrahydroquinolines as unnatural β-
aminoacids and considering that in the case of substrate A, a 
biocatalytic resolution of the corresponding amines is easy to 
realize conversely to the more difficult of derivative B.[6c, 6d] 
 
 
 
 
 
 
 
 
 
 
 
Table 1. AH of cyclic imines using the selected atropoisomeric ligands. 
 
Ent
ry 
Diphosp
hine 
Subst
rate 
Conversio
n %
[a] 
e.e.
 % 
1 (R)-
TetraMe-
BITIANP 
A 99 14 
(S) 
2 (R)-
BITIANP 
A 99 20 
(S) 
3 (R)-
TetraMe-
BITIOP 
A 99 54 
(S) 
4 (R)-
TetraMe-
BITIANP 
B 99 29 
(S,
R) 
5 (R)-
BITIANP 
B 99 32 
(S,
R) 
6 (R)-
TetraMe-
BITIOP 
B 99 51 
(S,
R) 
7
[b]
 (R)-
Synphos 
B 98 64 
(S,
R) 
8 (R)-
TetraMe-
BITIANP 
C 99 23 
(S) 
9 (R)-
BITIANP 
C 99 37 
(S) 
10 (R)-
TetraMe-
BITIOP 
C 99 63 
(S) 
11 (R)-
TetraMe-
BITIOP 
D 60 60 
(S) 
12 (R)-
TetraMe-
BITIOP 
E 68 45 
(S) 
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13
[c
] 
(R)-
TetraMe-
BITIOP 
F 96 64 
(R) 
14 (R)-
TetraMe-
BITIOP 
G traces 86
[d]
  
Reactions were conducted with 0.16 M solution substrate using 1 mol % iridium complex in toluene in the presence of DCDMH as additive (substrate:additive = 
10:1) at 50°C and 10 atm of H2 pressure for 24 h. [a] Conversion was obtained by HPLC using correction factor of 1.32 for A and 1.23 for F and G at λ = 283 nm 
and 220 nm.
[11]
 For product G d.e. >99% (syn). [b] Data reported in literature.
[8a]
 [c] Reaction conducted in THF at room temperature.
[12]
 [d] See the experimental 
section for HPLC conditions. 
As evinced in the Table 1 for all the substrates, the reduction 
proceeded from moderate to complete conversion. Different 
additives such as I2, 1,3-diiodo-5,5-dimethyl-hydantoin (DIDMH) 
or 1,3-dichloro-5,5-dimethyl-hydantoin (DCDMH).[13], different 
solvents, such as THF, DMC and toluene and different reaction 
conditions (H2 pressure and temperature) were evaluated (data 
not reported). 
As expected, an increase of the enantioselectivity was observed 
when the hydrogenation was conducted in the presence of 
TetraMe-BITIOP, the more basic diphosphine used, which is the 
best one for the enantioselective reduction of many substrates, 
resulting in 54% e.e. for A (Table 1, entry 3), 51% e.e. for B 
(Table 1, entry 6) and 63% e.e. in the reduction of C (Table 1, 
entry 10). It is worth noting that in the case of substrate B the 
reaction proceeded with excellent diastereoselectivity affording 
only syn diastereomers (d.e. > 99%). The results obtained in the 
presence of TetraMe-BITIOP are similar to those obtained with 
Synphos (Table 1, entry 7) considering the comparable 
electronic properties. In contrast, the more acid ligands, 
BITIANP and TetraMe-BITIANP, provided lower 
enantioselectivity.[14] 
The optimised protocol for the AH in the chosen substrates 
consists of [Ir(COD)Cl]2/TetraMe-BITIOP as catalyst, DCDMH as 
additive and toluene at 50°C for 24 h under 10 atm of H2. With 
the aim to expand the substrates diversity for AH, other four 
imines were investigated different in electronic and steric 
properties: two dihydroisoquinolines D and E, precursors of 
higenamine and norlaudanosine respectively, the quinaldine F 
and the sulfonyl imine G derived from saccharine. [5c, 6f, 6g, 15] In 
particular for substrate D a good 60% e.e. was obtained even if 
the reaction proceeded with a formation of a by-product, easily 
removed by an acid-base work-up procedure.[6g] When the steric 
hindrance increased, as in the case of substrate E, the 
enantioselectivity decreased to a modest 45%. For both the C 
derivatives, the reaction did not raise the complete conversion in 
24 h (Table 1, entries 11 and 12). In the case of substrate F, the 
best results were obtained again with DCDMH as the additive 
but the best reaction conversion and enantioselectivity were 
obtained using THF as solvent at room temperature (Table 1, 
entry 13). Changing completely the electronic properties of the 
imine, the reduction of substrate G did not proceed (Table 1, 
entry 14), underlining that the AH of this active imines gave good 
results only in presence of Pd(II)complexes as pre-catalysts.[16] 
While the 3,4-dihydroisoquinoline is often used as standard 
substrate for ATH considering their intrinsic electronic properties, 
quinolines and isoquinolines are less investigated. It is well-
known that Noyori-Ikariya complex containing Ts-DPEN as 
diamine ligand proved the catalyst of choice for the asymmetric 
transfer hydrogenation not only of ketones but also of imines.[3d, 
17] The search for an alternative to this tosylated diamine as 
source of chirality in transition metal complexes led our research 
group to synthesise two cyclic diamines that feature both the 
rigidity and the basicity of Ts-DPEN, even if not tosylated.[18] 
These ligands called CAMPY, and its 2-methyl derivative, Me-
CAMPY, have been successfully applied as ligands in 
iridium(III)-Cp* complexes for the ATH of substituted ketones 
providing good results in terms of yield and selectivity.[19] 
Starting from these encouraging premises, these catalysts were 
applied initially for screening the reaction conditions to the 
reduction of C using as well as reference ligand the free amine 
diphenylethylenediamine (DPEN) in an analogue iridium(III)-Cp* 
complex for a better comparison. The main advantage offered 
by this catalytic system is the possibility to operate under green 
conditions. In fact, the stability of the synthesised catalysts in an 
aqueous reaction environment or in a green solvent (iPrOH) 
prompted us to carry out the reaction under mild reaction 
conditions avoiding the use of an inert atmosphere and using 
different buffers (acetate pH 5, MES pH 6, MOPS pH 7, MOPS 
pH 8). 
 
Table 2. ATH of different cyclic imines in buffer. 
 
Entry Ligand Substrate pH Conversion %
[b]
 e.e.% 
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1 (S,S)-DPEN C 7 42 21 (S) 
2 (S)-Me-CAMPY C 7 99 43 (S) 
3 (S)-CAMPY C 6 99
[b] 
74 (S) 
4 (S)-CAMPY C 7 99
[b]
 76 (S) 
5 (S)-CAMPY C 8 99
[b]
 74 (S) 
6 (S)-CAMPY A 6 87
[c] 
- 
7 (S)-CAMPY A 7 85
[c]
 - 
8 (S)-CAMPY A 8 22
[c]
 - 
9 (S)-CAMPY B 6 - - 
10 (S)-CAMPY B 7 34 72 (S,R) 
11 (S)-CAMPY B 8 28 41 (S,R)  
12 (S)-CAMPY D 6 82 35 (S) 
13 (S)-CAMPY D 7 85 38 (S) 
14 (S)-CAMPY D 8 84 30 (S) 
15 (S)-CAMPY E 6 99 42 (S) 
16 (S)-CAMPY E 7 96 52 (S) 
17 (S)-CAMPY E 8 95 43 (S) 
18 (S)-CAMPY F 6 65 45 (R) 
19 (S)-CAMPY F 7 62 53 (R) 
20 (S)-CAMPY F 8 29 42 (R) 
21 (S)-CAMPY G 6 99 61
[d] 
22 (S)-CAMPY G 7 99 62
[d]
 
23 (S)-CAMPY G 8 89 58
[d]
 
All reactions were carried out for 18 h at 20°C using 1 mol % iridium complex in 1.2 M MOPS buffer for pH=7 and pH=8, in 1.2 M MES buffer for pH=6, 6 M 
HCOONa in all the buffers, [sub]f = 28 mM, [cat]f = 0.28 mM. [a] The reactions were carried out for 5 h. [b] Conversion was obtained by HPLC using correction 
factor of 1.3 for A, B, C, D and E at λ = 283 nm. Enantiomeric excess was determined using HPLC equipped with chiral OD-H column. For product B d.e. >99% 
(syn). [c] the only product results the ethyl 1,2-dihydroisoquinoline-4-carboxylate. [d] See the experimental section for HPLC conditions. 
Preliminary studies were first performed to select the best 
solvent and hydrogen donor. In this regard, buffers revealed the 
best choice if compared to water whereas iPrOH or physiological 
solution, led to a significant erosion in the reaction conversion 
(conversion <50% in 24 h in all cases for both CAMPY and Me-
CAMPY). In the same way the selection of hydrogen donor 
proved critical. HCOONa was selected among the others 
(HCOOH or azeotropic mixture 5:2=TEA:HCOOH) on the base 
of the achieved enantioselectivity, with a settled ratio of 20:1 to 
the substrate. In fact, by using a different hydrogen donor, a 
racemic mixture of the product was obtained in all cases. 
Conversely, the temperature variation (20°C, 40°C or 60°C) did 
not show any significant effect on conversion but caused a weak 
decrease in enantioselectivity (screening data not reported).  
The final pH of the solution was screened in a range of 5-8 
values, according with the assumption made by Bäckvall that 
protonated imines can be easily reduced by metal-hydride 
intermediates enhancing the enantioselectivity of the system.[20] 
A change in pH did not result in a better enantioselectivity in all 
cases but in a drop of the reaction rate specially at pH 5 (data 
not reported). Conversely, the reduction conversion of the 
precursor of salsolidine C remarkably raised up to 99% in only 5 
h in the case of the use of CAMPY as ligand at all different pH 
(Table 2, entries 3-5). As a result of this preliminary screening, 
the reactions for all the substrate were carried out using 
[IrCp*Cl2]2/CAMPY in MES or MOPS buffer (1.2 M, pH 6-8) in 
the presence of HCOONa (6 M) at 20°C.  
When the ATH reaction was carried out on the most challenging 
disubstituted isoquinoline B, the syn diasteroisomers were 
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obtained with an excellent d.e. (>99%) and an extremely 
appreciable e.e. in the case of CAMPY (Table 2, entry 10, 72% 
e.e.) although in a modest conversion (up to 34% e.e.). Most 
notably, the catalytic system resulted active only at pH 7 
whereas acidic conditions proved detrimental for the catalyst 
performance showing that, in this case, the reduction product 
was obtained only in traces. The reduction of isoquinolines, 
aromatic imines, resulted particularly demanding as it has been 
reported[8a] to take place through the formation of 1,2-
dihydroisoquinolines as intermediate. In a presence of a 
substituent in α position to N atom, this enamine is subjected to 
a rapid enamine-imine tautomerization process affording the 1,4-
dihydroisoquinoline that undergoes to a second reduction to the 
corresponding amine. In the case of substrate A, the lack of the 
substituent in α position might not allow the tautomerization 
process and the only obtained product resulted the prochiral 
ethyl 1,2-dihydroisoquinoline-4-carboxylate (Table 2, entries 6-8). 
Instead regarding the 3,4 dihydroquinoline D and E, the 
presence of benzylic substituent in 1 position of the molecules, 
brought on a decrease in enantioselectivity in comparison to 
their precursor C (Table 2, entries 12-17 vs entries 3-5) although 
the reaction proceeded with better conversion than those obtain 
with AH reduction process (Table 1, entries 11 and 12). 
Regarding the ATH of quinaldine F, in all cases the reaction rate 
in 18 h did not allow to obtain complete conversion and the 
enantioselectivity is comparable to that obtained with the 
substrate E with and e.e. up to 53% (Table 2, entries 18-20 vs 
entries 15-17). For the sulfonyl imines G, the ATH confirmed that 
the reaction rate resulted in very good yield in comparison of AH 
with a good e.e. obtained at pH 7 (Table 2, entry 22). 
Conclusions 
The obtained data underlined that for both the reduction 
methods the reaction rate and the enantioselectivity resulted 
comparable although with significant differences. The ATH 
proved to be the method of choice to obtain amines from 3,4 
dihydroquinolines, substrates C, D and E and for activated 
imines as the sulfonyl imine G. In fact, ATH reaction gave the 
best results at pH 7, either for substrate C leading to a complete 
conversion in only 5 h with a good 76% e.e. (Table 2, entry 4) or 
for G allowing to obtain a complete conversion with an 
appreciable e.e. (Table 1, entry 22, 62% e.e.). On the contrary, 
AH resulted a valid synthetic tool in the reduction of the most 
arduous isoquinolines (A and B) and quinolines (F) affording the 
chiral cyclic amines in quantitative yield for all the substrates 
with a significant 54% e.e. for a A, 51% e.e. for B and 64% e.e 
for F when TetraMe-BITIOP was used in iridium cyclooctadiene 
complex and in the presence of DCDMH (Table 1, entries 3, 6 
and 13). In conclusion, ATH resulted a valid alternative to AH 
only for the reduction of 3,4-dihydroisoquinoline and activated 
imines. In the case of the most demanding substrates, this 
approach need further investigation to overcome the limited 
conversion to the product especially considering the green 
reaction conditions that this system allowed to apply. 
Supporting Information Summary 
In Supporting Information are reported Experimental Procedures, 
NMR- spectra and HPLC spectra. 
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